Literature DB >> 19751063

Single-domain antibody-nanoparticles: promising architectures for increased staphylococcus aureus detection specificity and sensitivity.

Shannon Ryan1, Arnold J Kell, Henk van Faassen, Li-Lin Tay, Benoit Simard, Roger MacKenzie, Michel Gilbert, Jamshid Tanha.   

Abstract

Because antibodies are highly target-specific and nanoparticles possess diverse, material-dependent properties that can be exploited in order to label and potentially identify biomolecules, the development of antibody-nanoparticle conjugates (nanoconjugates) has huge potential in biodiagnostics. Here, we describe a novel superparamagnetic nanoconjugate, one whose recognition component is a single-domain antibody. It is highly active toward its target Staphylococcus aureus, displays long shelf life, lacks cross-reactivity inherent to traditional homologue whole antibodies, and captures a few dozen S. aureus cells in a mixed cell population with ~100% efficiency and specificity. We ascribe the excellent performance of our nanoconjugate to its single-domain antibody component and recommend it as a general purpose recognition element.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751063     DOI: 10.1021/bc900332r

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

1.  Chemiluminescent Enzyme Immunoassay and Bioluminescent Enzyme Immunoassay for Tenuazonic Acid Mycotoxin by Exploitation of Nanobody and Nanobody-Nanoluciferase Fusion.

Authors:  Feng Wang; Zhen-Feng Li; Yuan-Yuan Yang; De-Bin Wan; Natalia Vasylieva; Yu-Qi Zhang; Jun Cai; Hong Wang; Yu-Dong Shen; Zhen-Lin Xu; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-08-11       Impact factor: 6.986

2.  Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infections.

Authors:  Shakeeba Waseh; Pejman Hanifi-Moghaddam; Russell Coleman; Michael Masotti; Shannon Ryan; Mary Foss; Roger MacKenzie; Matthew Henry; Christine M Szymanski; Jamshid Tanha
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

Review 3.  Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Toxins (Basel)       Date:  2010-05-07       Impact factor: 4.546

Review 4.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

5.  Isolation of a highly thermal stable lama single domain antibody specific for Staphylococcus aureus enterotoxin B.

Authors:  Russell R Graef; George P Anderson; Katherine A Doyle; Dan Zabetakis; Felicia N Sutton; Jinny L Liu; Joseline Serrano-González; Ellen R Goldman; Lynn A Cooper
Journal:  BMC Biotechnol       Date:  2011-09-21       Impact factor: 2.563

Review 6.  Single Domain Antibodies as New Biomarker Detectors.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Qin Cheng; Candy Chuah; James McCarthy
Journal:  Diagnostics (Basel)       Date:  2017-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.